Disitamab vedotin, an antibody-drug conjugate (ADC), targets HER2-expressing cancer cells. It works by binding to HER2, being ...

Pharma giant Pfizer and Arvinas’s human epidermal growth factor receptor 2 (HER2) negative breast cancer therapy, ...

Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United States, if required, as the Trump administration threatens numerous tariffs ...

While most of Pfizer's generic drugs are produced overseas, Bourla said the company has a large manufacturing network in the US. "We have 13 manufacturing sites in the US right now, up and running ...

The trial enrolled 624 patients at sites in 26 countries who had previously received treatment ... In July 2021, Arvinas announced a global collaboration with Pfizer for the co-development and ...

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, April 29, 2025. The purpose ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

March 3 (Reuters) - Pfizer (PFE.N), opens new tab CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United States, if required, as the ...

Clinical trials for the Pfizer collaboration are expected to commence ... evaluating ivonescimab monotherapy against pembrolizumab, has begun site activation in the U.S. and will expand globally ...

Pfizer already has 13 U.S. manufacturing sites up and running, including several “megasites” for sterile injectables and antibody manufacturing, according to Bourla. “We have all the ...

Pfizer, one of the world’s largest pharmaceutical companies, has announced that David Lepoittevin will be its new country manager for Belgium and Luxembourg.